These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 535329)

  • 1. [Use of rifampicin in venous perfusion in tuberculosis].
    Perna G; Natale F
    Clin Ter; 1979 Jul; 90(1):63-73. PubMed ID: 535329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
    Górecki R; Stanek S
    Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229
    [No Abstract]   [Full Text] [Related]  

  • 3. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R; Piekarniak K; Wyczólkowski M; Martyniak K
    Pneumonol Pol; 1977 Feb; 45(2):125-30. PubMed ID: 840724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study on regimen using tuberactinomycin-N intermittent and daily and viomycin intermittent in combination with rifampicin. The 15th Series-A Study].
    Kekkaku; 1973 Apr; 48(4):129-34. PubMed ID: 4124626
    [No Abstract]   [Full Text] [Related]  

  • 8. [Corrective possibilities of rifampicin in ineffective chemotherapy of destructive pulmonary tuberculosis in children and adolescents].
    Ivaniuta OM; Il'nitskiĭ IG; Panasiuk AV; Kunichkina SA
    Probl Tuberk; 1987; (8):30-3. PubMed ID: 3684986
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early results of rifampicin treatment combined with other antitubercular agents in patients with recent and chronic pulmonary tuberculosis].
    Zduńczyk-Pawełek H; Kochnowski G; Polońska A
    Pneumonol Pol; 1979 Feb; 47(2):97-105. PubMed ID: 432119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Chukanov VI
    Probl Tuberk; 1978 Jun; (6):14-20. PubMed ID: 353801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rabukhin AE; Gol'dshteĭn VD; Khodakevich LIa
    Probl Tuberk; 1974; (7):14-8. PubMed ID: 4409887
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inactivation of glucocorticoid hormones by rifampicin in the treatment of patients with pulmonary tuberculosis].
    Spesivtsev OG; Basov PV
    Probl Tuberk; 1988; (12):27-8. PubMed ID: 3244680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis].
    Sodikov ES; Abrarov BA
    Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
    German AK; Syrovatka IuA; Bondarenko VP
    Vrach Delo; 1985 Oct; (10):98-100. PubMed ID: 4090447
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice].
    Pershin GN; Zykova TN; Kutchak SN
    Probl Tuberk; 1977 Jan; (1):64-9. PubMed ID: 834763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 20. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.